| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.056 | 0.8 |